Advertisement

Topics

Some head and neck cancer patients benefit from continued checkpoint inhibitor treatment

20:00 EDT 2 Apr 2017 | AAAS

(Dana-Farber Cancer Institute) New research suggests that some patients with head and neck cancers can benefit by continuing treatment with an immunotherapy drug after their tumors show signs of enlargement according to investigators at Dana-Farber Cancer Institute.

Original Article: Some head and neck cancer patients benefit from continued checkpoint inhibitor treatment

NEXT ARTICLE

More From BioPortfolio on "Some head and neck cancer patients benefit from continued checkpoint inhibitor treatment"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...